Cleary, Davis Polk Lead Diabetes Biz MiniMed's $560M IPO
By Jade Martinez-Pogue · March 6, 2026, 12:42 PM EST
Medtronic's diabetes-focused spin-off MiniMed Group began trading publicly Friday after pricing a $560 million initial public offering, well below the expected target of $742 million....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login